Imax price target raised to $47 from $42 at Rosenblatt

Rosenblatt analyst Steve Frankel raised the firm’s price target on Imax (IMAX) to $47 from $42 and keeps a Buy rating on the shares following the investor day. The firm believes the stage is set for Imax to see growth and margin expansion in the years ahead. The analyst upped estimates and is “pounding the table on the stock.” Imax is “on a roll” given its diversified set of content partners, “rapidly growing” local language business, “strong” film slate and “significant” market share gains, the analyst tells investors in a research note.